Plant Summary
Plant Information
TCMBank_ID: | TCMBANKHE002642 |
ID: | TCMBANKHE002642 |
功能与主治: | Phlegm-heat cough, pulmonary welling abscess, intestinal welling abscess, white turbidity, vaginal discharge, beriberi, edema, strangury syndrome. |
药用植物名: | 冬瓜子 |
治疗类型: | 化痰药 |
TCM_ID_id: | 7293 |
SymMap_id: | 110 |
植物对应的化合物
| 化合物ID | 化合物名 | 别名 | 分子式 | 分子质量 | Smiles |
|---|
| TCMBANKIN000962 | campesterol | campesterol ; FT-0082089; Augelicincampesterol; (24R)-5-Ergosten-3; (1R,3AS,3BR,9AS,9BS,11AR)-1-[(2R,5R)-5,6-DIMETHYLHEPTAN-2-YL]-9A,11A-DIMETHYL-1H,2H,3H,3AH,3BH,4H,5H,5AH,6H,9H,9BH,10H,11H-CYCLOPENTA[A]PHENANTHREN-7-OL; A-ol; 24(R)-Ergost-5-en-3beta-ol; 24alpha-Methyl-5-cholesten-3beta-ol; AK307302; SC-66911; (8R,9S,10S,13R,14S,17R)-17-((2R,5R)-5,6-Dimethylheptan-2-yl)-10,13-dimethyl-4,5,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-ol; AKOS027320474; MFCD00010475; Campesterin; MolPort-035-882-175 | C28H48O | 400.68 | CC(C)C(C)CCC(C)C1CCC2C1(CCC3C2CC=C4C3(CCC(C4)O)C)C |
| TCMBANKIN001603 | debneyol | AC1NSU90; 2-[(2R,8aR)-8,8a-dimethyl-2,3,5,6,7,8-hexahydro-1H-naphthalen-2-yl]propane-1,2-diol | C15H26O2 | 238.37 g/mol | CC1CCCC2=CCC(CC12C)C(C)(CO)O |
| TCMBANKIN001719 | lecithin | phosphatidylcholine; 1-Lignoceryl-2-eicsoic acid; 1-Lignoceryl-2-eicsoate; 1-Lignoceryl-2-eicsoatetraenoyl-sn-glycero-3-phosphocholine | C52H98NO7P | 880.3 g/mol | CCCCCCCCCCCCCCCCCCCCCCCCOCC(COP(=O)([O-])OCC[N+](C)(C)C)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC |
| TCMBANKIN002902 | hexaethyl benzene | C18H30 | 246.43 | CCC1=C(C(=C(C(=C1CC)CC)CC)CC)CC | |
| TCMBANKIN004264 | tetradymol | 3,4a,5-trimethyl-4,5,6,7,8,9-hexahydrobenzo[f][1]benzofuran-8a-ol; AC1MR4OB | C15H22O2 | 234.33 g/mol | CC1CCCC2(C1(CC3=C(C2)OC=C3C)C)O |
| TCMBANKIN013604 | 1,5-naphthalene diol | C10H8O2 | 160.17 | C1=CC2=C(C=CC=C2O)C(=C1)O | |
| TCMBANKIN014992 | 1,2,9,10-tetradehydroaristolane | AOKPBPDKGDLBCJ-UHFFFAOYSA-N; CTK8I2950; AC1NT0VM; 1,1,7,7a-tetramethyl-2,6,7,7b-tetrahydro-1aH-cyclopropa[a]naphthalene; 1H-Cyclopropa[a]naphthalene, 1a,2,6,7,7a,7b-hexahydro-1,1,7,7a-tetramethyl-, [1aR-(1a.alpha.,7.alpha.,7a.alpha.,7b.alpha.)]-; 1H-Cyclopropa[a]naphthalene, 1a,2,6,7,7a,7b-hexahydro-1,1,7,7a-tetramethyl-, (1aR,7R,7aR,7bS)-; 1,2,9,10-Tetradehydroaristolane | C15H22 | 202.33 g/mol | CC1CC=CC2=CCC3C(C12C)C3(C)C |
| TCMBANKIN015594 | phosphatidylinositol | 1-Phosphatidyl-D-myo-inositol; Phosphatidylinositol; Phosphatidyl-1D-myo-inositol; 1-Phosphatidyl-1D-myo-inositol; Phosphatidylinositols, soya; 1-Phosphatidyl-myo-inositol; (3-Phosphatidyl)-1-D-inositol | C11H19O13P | 390.23 g/mol | C(C(COP(=O)(O)OC1C(C(C(C(C1O)O)O)O)O)OC=O)OC=O |
| TCMBANKIN017747 | aristolan-9β-ol | C15H26O | CC1CCCC2C1(C3C(C3(C)C)CC2O)C | ||
| TCMBANKIN017993 | vitamin c | D01CWN; Cell C; Ronotec 100; P 1110; Suncoat VC 40; D-threo-hex-2-enoic acid gamma-lactone; Citrovit; 2-o-(beta-d-glucopyranosyl)-ascorbic acid_qt; Juvamine; SCHEMBL13468284; Vasc; CHEBI:51384; D-Lyxoascorbic acid; CHEMBL1253320; AK481251; Chewcee; D-xyloascorbic acid; C8DQ5M1Y1E; MLS001066386; AK322241; Ascorbic acid, D-; AC1LD8K5; E 300; Scorbu C; 10504-35-5; Ascorbicacid; l(+)-ascorbic acid; ZINC100006137; L-ascorbate (vitamin C); (5S)-5-[(1R)-1,2-dihydroxyethyl]-3,4-dihydroxyfuran-2(5H)-one; (+)-Ascorbic acid; UNII-C8DQ5M1Y1E; Ascorbinsaure; Ceklin; VC 97; (2S)-2-[(1R)-1,2-bis(oxidanyl)ethyl]-4,5-bis(oxidanyl)furan-3-one; Vicin; L-ascorbate acid; L-ascorbic acid; L-dehydroascorbic acid; ascorbate; D-threo-hex-2-enono-1,4-lactone; Kangbingfeng; D-Ascorbic acid; Viscorin 100M; ZINC100028197; (2S)-2-[(1R)-1,2-dihydroxyethyl]-4,5-dihydroxy-3-furanone; L-Ascorbic acid (8CI,9CI); Proscorbin Redoxon Ribena Ronotec 100; Hex-2-enonic acid gamma-lactone, L-threo; (5S)-5-[(1R)-1,2-dihydroxyethyl]-3,4-dihydroxy-2,5-dihydrofuran-2-one; Ascorbic acid; DL-Ascorbic acid; AKOS000278050; Cebion, gamma-lactone; F91F7DA3-A3D5-4FB4-A6E7-C497C48D192A; GTPL4651; SMR000471843; Xyloascorbic acid, L-; Rontex 100; Rovimix C; (2S)-2-[(1R)-1,2-dihydroxyethyl]-4,5-dihydroxyfuran-3-one; A828310 | C6H8O6 | 176.12 | C(C(C1C(=C(C(=O)O1)O)O)O)O |
| TCMBANKIN018424 | nardostachone | (6R)-4,4a-dimethyl-6-propan-2-yl-5,6-dihydronaphthalen-2-one; AC1NSYYO | CC1=CC(=O)C=C2C1(CC(C=C2)C(C)C)C | ||
| TCMBANKIN020291 | eudesobovatol a | 125196-77-2; Eudesobovatol A; C10562; SCHEMBL4742784; AC1L9DHK; DTXSID60331968; 2-[[(1R,4aR,7R,8aR)-7-(2-hydroxypropan-2-yl)-1,4a-dimethyl-2,3,4,5,6,7,8,8a-octahydronaphthalen-1-yl]oxy]-4-prop-2-enyl-6-(4-prop-2-enylphenoxy)phenol; CHEBI:4915 | C33H44O4 | 504.7 g/mol | CC12CCCC(C1CC(CC2)C(C)(C)O)(C)OC3=CC(=CC(=C3O)OC4=CC=C(C=C4)CC=C)CC=C |
| TCMBANKIN020522 | valeranone | LS-95105; HDVXJTYHXDVWQO-NWANDNLSSA-N; (4aR,7S,8aS)-4a,8a-dimethyl-7-propan-2-yl-3,4,5,6,7,8-hexahydro-2H-naphthalen-1-one; (4aalpha,7beta,8aalpha)-Octahydro-4a,8a-dimethyl-7-(1-methylethyl)-1(2H)-naphthalenone; AC1L57JT; 55528-90-0; (4AR,7S,8AS)-7-ISOPROPYL-4A,8A-DIMETHYL-HEXAHYDRO-2H-NAPHTHALEN-1-ONE; 1803-39-0; Valeranone; C16813; CHEBI:80748; Yatamanson | C15H26O | 222.37 g/mol | CC(C)C1CCC2(CCCC(=O)C2(C1)C)C |
| TCMBANKIN026474 | 9-aristolen-1-α-ol | (1aR,7bS)-1,1,7,7a-tetramethyl-2,4,5,6,7,7b-hexahydro-1aH-cyclopropa[a]naphthalen-4-ol; 9-aristolen-1-alpha-ol; AC1NSZ1P | C15H24O | 220.35 g/mol | CC1CCC(C2=CCC3C(C3(C12)C)(C)C)O |
| TCMBANKIN027164 | orotic acid | 1K54797G2Z; Orotic acid, monosodium salt; DTXSID1021083; ACM456724; sodium 2,6-dioxo-1,2,3,6-tetrahydropyrimidine-4-carboxylate; X4064; AC1Q1W65; FT-0687996; Orotic acid, sodium salt; RP23926; J-009152; 154-85-8; oroticacid; sodium 2,6-dioxo-1,2,3,6-tetrahydro-4-pyrimidinecarboxylate; AK396116; Sodium 1,2,3,6-tetrahydro-2,6-dioxopyrimidine-4-carboxylate; UNII-1K54797G2Z; AC1Q1VUY; Sodium orotate; EINECS 205-834-0; 6-Carboxy-2,4-dihydroxy-pyrimidine; 456-72-4; LS-7630; 6-Carboxy-2,4-dihydroxy- pyrimidine; sodium 2,6-dihydroxypyrimidine-4-carboxylate; CHEBI:132101; CTK4C8432; 4-Pyrimidinecarboxylicacid, 1,2,3,6-tetrahydro-2,6-dioxo-, sodium salt (1:1); SCHEMBL193604; OROTIC ACID MONOSODIUM SALT; Monosodium orotate; Monosodium orolate; CCRIS 685; MolPort-023-222-298; BG00908735; 6-Carboxy-2,4-dihydroxypyrimidine monosodium salt; AKOS024319298; 4-Pyrimidinecarboxylic acid, 1,2,3,6-tetrahydro-2,6-dioxo-, sodium salt, (1:1); C5H3N2NaO4; ZTHMWDSJKLNDTE-UHFFFAOYSA-M; OROTIC ACID, NA SALT; J-518481 | C5H3N2NaO4 | 178.08 g/mol | C1=C(NC(=O)NC1=O)C(=O)[O-].[Na+] |
| TCMBANKIN028126 | calarenol | AC1O44KO; (1aR,7S,7bS)-1,1,7,7a-tetramethyl-1a,2,3,5,6,7b-hexahydrocyclopropa[a]naphthalen-7-ol | C15H24O | CC1(C2C1C3(C(=CCCC3(C)O)CC2)C)C | |
| TCMBANKIN028414 | n-hexacosanyl isovalerate | AC1NSWAJ; n-Hexacosanyl isovalerate; hexacosyl 3-methylbutanoate | C31H62O2 | 466.8 g/mol | CCCCCCCCCCCCCCCCCCCCCCCCCCOC(=O)CC(C)C |
| TCMBANKIN029758 | Isovaleroxy-hydroxy dihydrovaltrate | isovaleroxy-hydroxy dihydrovaltrate; [1-acetyloxy-4a-hydroxy-6-(3-methylbutanoyloxy)spiro[1,5,6,7a-tetrahydrocyclopenta[c]pyran-7,2'-oxirane]-4-yl]methyl 3-methyl-2-(3-methylbutanoyloxy)butanoate; AC1NSX6L | C27H40O11 | 540.67 | CC(C)CC(=O)OC1CC2(C(C13CO3)C(OC=C2COC(=O)C(C(C)C)OC(=O)CC(C)C)OC(=O)C)O |
| TCMBANKIN032814 | sphingomyelin | 493.73 | CCCCCCCCCCCCCC=CC(C(COP(=O)([O-])OCC[N+](C)(C)C)NC(=O)CCCCCCCCCC=CCCCCCC)O | ||
| TCMBANKIN032965 | Sphingoid | Bio1_000803; Bio2_000726; NCGC00024697-03; KBio3_000491; C00319; (E,2S,3R)-2-aminooctadec-4-ene-1,3-diol; Bio2_000246; erythro-4-Sphingenine; 85621_FLUKA; D-(+)-erytho-4-trans-Sphingenine; CHEBI:26743; 4-Octadecene-1,3-diol, 2-amino-, (R-(R*,S*-(E)))-; 4-Octadecene-1,3-diol, 2-amino-, (R-(R*,S*-(E))); NCGC00024697-06; BSPBio_001526; (2S,3R,4E)-2-amino-4-octadecene-1,3-diol; Bio1_001292; 4-trans-Sphingenine; KBioGR_000246; SMP1_000277; trans-4-sphingenine; 4-Octadecene-1,3-diol, 2-amino-, (E)-D-erythro- (8CI); (E)-2-Amino-4-octadecan-1,3-diol; 4-Octadecene-1,3-diol, 2-amino-, (2S,3R,4E)- (9CI); Lopac0_001049; IDI1_033996; NCGC00024697-05; G-1251; 4-octadecene-1,3-diol, 2-amino-, (2S,3R,4E)-; D-erythro-Sphingosine; CCRIS 6899; 2-Aminooctadec-4-ene-1,3-diol; KBio2_002814; (2S,3R)-2-aminooctadec-4-ene-1,3-diol; KBio3_000492; BiomolKI2_000042; 4-Sphingenine; (4E)-sphing-4-enine; (2S,3R)-Sphingosine; (4E)-sphingenine; D-erythro-C18-Sphingosine; KBioSS_000246; C18-Sphingosine; erythro-C18-Sphingosine; (-)-D-erythro-Sphingosine; (2S,3R,4E)-2-aminooctadec-4-ene-1,3-diol; S7049_SIGMA; Erythrosphingosine; D-Sphingosine; trans-D-erythro-2-amino-4-octadecene-1,3-diol; Sphing-4-enine; 123-78-4; KBio2_000246; LMSP01010001; KBio2_005382; CBiol_002028; D-<i>erythro-</i>Sphingosine, Free Base, High Purity; 4-Octadecene-1,3-diol, 2-amino-, [R-[R*,S*-(E)]]-; EINECS 204-651-3; Bio1_000314; BiomolKI_000034; CHEBI:16393 | C18H37NO2 | 299.49 | CCCCCCCCCCCCCC=CC(C(CO)N)O |
| TCMBANKIN036707 | 4-methyl-1,2-dithio-3-cyclopentene | AC1NSYBZ; 4-methyl-1,2-dithiacyclopentene; SCHEMBL2929220; 4-methyl-3H-dithiole | C4H6S2 | 118.2 g/mol | CC1=CSSC1 |
| TCMBANKIN036913 | naringenin | (2S)-5,7-dihydroxy-2-(4-hydroxyphenyl)chroman-4-one; ZINC1785; Spectrum2_000325; 2,3-Dihydro-5,7-dihydroxy-2-(4-hydroxyphenyl)-4H-1-benzopyran-4-one; (-)-Naringenin; SDCCGMLS-0066570.P001; (2R)-5,7-dihydroxy-2-(4-hydroxyphenyl)-2,3-dihydrochromen-4-one; MLS000574861; KBio2_000727; CHEBI:50201; HMS3468H18; ALBB-015405; NCGC00017346-01; BBL010488; AJ-08090; DivK1c_000118; BB 0261506; (S)-2,3-dihydo-5,7-dihydroxy-2-(4-hydroxyphenyl)-4H-1-benzopyran-4-one; CAS-480-41-1; KBio3_001454; SC-85987; 4H-1-benzopyran-4-one, 2,3-dihydro-5,7-dihydroxy-2-(4-hydroxyphenyl)-, (2R)-; AIDS-001417; NINDS_000118; SCHEMBL17166263; Spectrum3_000567; 2,3-dihydro-5,7-dihydroxy-2-(4-hydroxyphenyl)-4-benzopyrone; (2R)-naringenin; (2S)-5,7-dihydroxy-2-(4-hydroxyphenyl)-4-chromanone; BSPBio_001954; BB_NC-1001; MCULE-5852778653; NCGC00163598-01; BG01564988; MFCD03265520; naringenin ; 4H-1-Benzopyran-4-one, 2,3-dihydro-5,7-dihydroxy-2-(4-hydroxyphenyl)-, (2S)-; (2R)-5,7,4'-trihydroxyflavone; AKOS004119880; CHEBI:17846; ST24036200; AC1LDI7C; KBioGR_000508; ZINC00156701; Phytochemistry 8: 127 (1969); R6691; Asahina; 4',5, 7-Trihydroxyflavanone; N1370; (2S)-5,7-dihydroxy-2-(4-hydroxyphenyl)-2,3-dihydro-4H-chromen-4-one; C00509; 480-41-1; KBio2_003295; (2R)-4',5,7-trihydroxyflavanone; (+)-naringenin; Spectrum_000247; ZB000410; NAR; pelargidanon 1602; (R)-naringenin; IDI1_000118; STK801623; Spectrum5_001423; MolPort-002-507-277; Spectrum4_000124; 17654-19-2; KBio1_000118; KBioSS_000727; (+)-(2R)-5,7-dihydroxy-2-(4-hydroxyphenyl)chroman-4-one; (2R)-4',5,7-trihydroxyflavan-4-one; NCGC00016457-01; STOCK1N-05989; KBio2_005863; 5,7-Dihydroxy-2-(4-hydroxyphenyl)-2,3-dihydro-4H-chromen-4-one; AIDS001417; BG00617674; TNP00287; (2R)-5,7-dihydroxy-2-(4-hydroxyphenyl)-2,3-dihydro-4H-chromen-4-one; SPECTRUM1500746; YSO1; SMR000156272; 4',5,7-triOH-Flavone; SPBio_000329 | C15H12O5 | 272.253 | c1(O[H])c([H])c([H])c([C@]2([H])Oc(c([H])c(O[H])c([H])c3O[H])c3C(=O)C2([H])[H])c([H])c1[H] |
| TCMBANKIN037206 | Simiarenol | 6OU4M247SJ; MolPort-035-706-328; (3R,3AR,5AR,5BS,9S,11AS,11BR,13AS,13BR)-3-ISOPROPYL-3A,5A,8,8,11B,13A-HEXAMETHYL-1H,2H,3H,4H,5H,5BH,6H,9H,10H,11H,11AH,12H,13H,13BH-CYCLOPENTA[A]CHRYSEN-9-OL; (3R,3aR,5aR,5bS,9S,11aS,11bR,13aS,13bR)-3a,5a,8,8,11b,13a-hexamethyl-3-(propan-2-yl)-2,3,3a,4,5,5a,5b,6,8,9,10,11,11a,11b,12,13,13a,13b-octadecahydro-1H-cyclopenta[a]chrysen-9-ol; Simiaren-3beta-ol; ZINC56874814; CHEBI:81371; DTXSID00167162; SCHEMBL2337338; Simiarenol; D:B-Friedo-B':A'-neogammacer-5-en-3-ol, (3beta)-; W2408; 1615-94-7; beta-Simiarenol; C17901; BG01135934; UNII-6OU4M247SJ; AKOS032948287 | 426.72 | ||
| TCMBANKIN037308 | β-Eudesmol | 2-Naphthaleneethanol, decahydro-alpha,alpha,4a-trimethyl-8-methylene-; SCHEMBL12633040; beta-eudesmol; 2-[(2R,4aR,8aS)-4a-methyl-8-methylene-decalin-2-yl]propan-2-ol; 17790_FLUKA; 2-Naphthalenemethanol, decahydro-8-methylene-alpha,alpha,4a-trimethyl-, (2R-(2-alpha,4a-alpha,8a-beta)-; 2-[(2R,4aR,8aS)-4a-methyl-8-methylidene-1,2,3,4,5,6,7,8a-octahydronaphthalen-2-yl]propan-2-ol; 3beta-(1-Hydroxy-1-methylethyl)-5-methylene-8abeta-methyldecahydronaphthalene; Beta- Eudesmol; (2R,4aR,8aS)-Decahydro-8-methylene-alpha,alpha,4a-trimethyl-2-naphthylmethanol; β- eudesmol; Eudesm-4(14)-en-11-ol (8CI); beta-Selinenol; rel-2-[(2R,4aR,8aS)-4a-methyl-8-methylenedecahydronaphthalen-2-yl]propan-2-ol; 2-naphthalenemethanol, decahydro-alpha,alpha,4a-trimethyl-8-methylene-, (2R,4aR,8aS)-; C09664; InChI=1/C15H26O/c1-11-6-5-8-15(4)9-7-12(10-13(11)15)14(2,3)16/h12-13,16H,1,5-10H2,2-4H3/t12-,13+,15-/m1/s; beta-eudesmol ; 2-[(2R,4aR,8aS)-4a-methyl-8-methylene-2-decalinyl]propan-2-ol; AC1NSVC6; 2-[(2R,4aR)-4a-methyl-8-methylidene-1,2,3,4,5,6,7,8a-octahydronaphthalen-2-yl]propan-2-ol; beta-Eudesmol; beta- eudesmol; 473-15-4; 4(15)-eudesmen-11-ol | 222.37 | ||
| TCMBANKIN037416 | narchinol a | C12H14O3 | 206.24 g/mol | CC1CC(=O)C=C2C1(C(C=CC2=O)O)C | |
| TCMBANKIN037564 | kanshone a | C15H22O2 | 234.33 g/mol | CC1CCC=C2C1(C(C=CC2=O)C(C)(C)O)C | |
| TCMBANKIN038735 | nardostachin | 3-methylbutanoic acid [(1S,4aS,6S,7R,7aS)-6-hydroxy-7-methyl-4-[(3-methyl-1-oxobutoxy)methyl]-1,4a,5,6,7,7a-hexahydrocyclopenta[c]pyran-1-yl] ester; AC1L5267; 114687-82-0; DTXSID80150830; 3-methylbutyric acid [(1S,4aS,6S,7R,7aS)-6-hydroxy-4-(isovaleryloxymethyl)-7-methyl-1,4a,5,6,7,7a-hexahydrocyclopenta[c]pyran-1-yl] ester; [(1S,4aS,6S,7R,7aS)-6-hydroxy-7-methyl-1-(3-methylbutanoyloxy)-1,4a,5,6,7,7a-hexahydrocyclopenta[c]pyran-4-yl]methyl 3-methylbutanoate; Butanoic acid, 3-methyl-, (1,4a,5,6,7,7a-hexahydro-6-hydroxy-7-methyl-1-(3-methyl-1-oxobutoxy)cyclopenta(c)pyran-4-yl)methyl ester, (1S-(1alpha,4aalpha,6alpha,7alpha,7aalpha))-; [(1S,4aS,6S,7R,7aS)-6-hydroxy-7-methyl-4-(3-methylbutanoyloxymethyl)-1,4a,5,6,7,7a-hexahydrocyclopenta[c]pyran-1-yl] 3-methylbutanoate; nardostachin | C20H32O6 | 368 | [C@@]12([H])[C@@]([H])([C@@]([H])(C([H])([H])[H])[C@@]([H])(O[H])C1([H])[H])[C@]([H])(OC(=O)C([H])([H])C([H])(C([H])([H])[H])C([H])([H])[H])OC([H])=C2C([H])([H])OC(C([H])([H])C([H])(C([H])([H])[H])C([ H])([H])[H])=O |
| TCMBANKIN039389 | nardosinonediol | C15H24O3 | 252.35 g/mol | CC1CCC=C2C1(C(C(CC2=O)O)C(C)(C)O)C | |
| TCMBANKIN041253 | debilone | AC1NSU8X; (1aR,7bS)-3-hydroxy-1,1,7,7a-tetramethyl-1a,2,3,6,7,7b-hexahydrocyclopropa[a]naphthalen-5-one | C15H22O2 | 234.33 g/mol | CC1CC(=O)C=C2C1(C3C(C3(C)C)CC2O)C |
| TCMBANKIN041537 | kanshone c | C15H20O3 | 248.32 g/mol | CC1CCC2C3(C1(C4C(C4(C)C)C(=O)C3=O)C)O2 | |
| TCMBANKIN044291 | kanshone d | C15H22O4 | 266.333 | ||
| TCMBANKIN044355 | Nardofuran | 250.333 | |||
| TCMBANKIN044594 | Jatropham | (5S)-3-Methyl-5-hydroxy-3-pyrroline-2-one; AC1NRZ9K; (2S)-2-hydroxy-4-methyl-1,2-dihydropyrrol-5-one | 113.11 g/mol | ||
| TCMBANKIN044595 | Kanshone B | 266.33 g/mol | |||
| TCMBANKIN044600 | Isonardosinone | 250.333 | |||
| TCMBANKIN045358 | oroselol | MCULE-7376606158; AC1Q6A10; 1891-25-4; 8-(1-hydroxy-1-methyl-ethyl)furo[2,3-h]chromen-2-one; 8-(2-hydroxypropan-2-yl)furo[2,3-h]chromen-2-one; 8-(2-oxidanylpropan-2-yl)furo[2,3-h]chromen-2-one; 2H-Furo[2,3-h]-1-benzopyran-2-one,8-(1-hydroxy-1-methylethyl)-; CTK4E0041; AKOS030536206; A815584; 8-(2-HYDROXYPROPAN-2-YL)-2H-FURO[2,3-H]CHROMEN-2-ONE; NCGC00385867-01!8-(2-hydroxypropan-2-yl)furo[2,3-h]chromen-2-one; AK561872; oroselol; 2H-Furo(2,3-h)-1-benzopyran-2-one, 8-(1-hydroxy-1-methylethyl)-; AC1L4NWX; MolPort-019-936-899; 8-(1-hydroxy-1-methylethyl)-2-furo[2,3-h]chromenone; ZINC5357577; 8-(2-hydroxypropan-2-yl)-2-furo[2,3-h][1]benzopyranone | C14H12O4 | 244.243 | c1([H])c(c(OC(=O)C([H])=C2[H])c2c([H])c3[H])c3oc1C(C([H])([H])[H])(C([H])([H])[H])O[H] |
| TCMBANKIN046159 | Calaxin | 15-deoxygoiazensolide; D0VD3M; C09353; 2-Propenoic acid, 2-methyl-, 2,3,3a,4,5,6,7,11a-octahydro-6,10-dimethyl-3-methylene-2,7-dioxo-6,9-epoxycyclodeca(b)furan-4-yl ester, (3aR-(3aR*,4R*,6R*,10Z,11aR*))-; CHEBI:3302; Calaxin; 30412-86-3; CHEMBL189790 | 344.4 g/mol | ||
| TCMBANKIN046891 | Nardoguaianone K | 234.33 g/mol | |||
| TCMBANKIN047060 | Kanshone E | 264.317 | |||
| TCMBANKIN047094 | nardonoxide | CC1CC(=O)C2=C1C(C3(CCC2(O3)C)C(C)C)O | |||
| TCMBANKIN049251 | nardosinone | NSC133568; AC1L5TPP; 1,1,9,9a-tetramethyl-3a,4,7,8,9,9b-hexahydronaphtho[2,1-c]dioxol-5-one; CTK7H3177; NSC-133568; nardosinone; 1,1,9,9a-tetramethyl-1,3a,4,7,8,9,9a,9b-octahydro-5h-naphtho[2,1-c][1,2]dioxol-5-one | C15H22O3 | 250.333 | C1([H])([H])C([H])=C(C(=O)C([H])([H])[C@@]([H])(OOC2(C([H])([H])[H])C([H])([H])[H])[C@@]23[H])[C@]3(C([H])([H])[H])[C@]([H])(C([H])([H])[H])C1([H])[H] |
| TCMBANKIN050114 | Nardoguaianone J | AC1NSYYI; Nardoguaianone K; (3R,8S)-8-hydroxy-3,8-dimethyl-5-propan-2-yl-2,3,6,7-tetrahydroazulen-1-one | 234.33 g/mol | ||
| TCMBANKIN057918 | urea | 1-Benzhydryl-3-[4-(methoxy-quinolin-8-ylamino)-pentyl]-urea; 1-(3-benzylphenyl)-3-[4-[(3-methoxy-1-naphthyl)amino]pentyl]urea; UR; Mocovina [Czech]; 51457_FLUKA; Aquacare HP; Keratinamin Kowa; KBio2_003720; 51456_FLUKA; NCGC00090892-03; NCI-C02119; 174693-33-5; 51460_FLUKA; EPA Pesticide Chemical Code 085702; KBioGR_001775; 173994-65-5; Carbaderm; 173144-80-4; Alphadrate; AIDS-003652; NSC 34375; KBio1_000086; Pastaron; HSDB 163; U7129_SIGMA; Carbamimic acid; Carbonyldiamine; c0165; 299367_ALDRICH; SPBio_001263; Ureaphil; Karbamid; NCGC00090892-01; Urea ammonium nitrate solution; Pastaron soft; Carmol 40; B-I-K; Urevert; Urea-13C; Panafil; U6504_SIGMA; 51465_FLUKA; 57-13-6; Keratinamin; Spectrum4_001168; Elaqua XX; H2NC(O)NH2; U1250_SIGMA; KBio2_001152; Urepeal L; KBio3_002843; ST5214565; URE; BSPBio_003341; D00023; Urea [JAN]; AI3-01202; NCGC00090892-02; Benural 70; WLN: ZVZ; DivK1c_000086; Pastaron (TN); carmol; Urea perhydrate; Polyurea; Hyanit; NINDS_000086; Eucerin 10% Urea Lotion; InChI=1/CH4N2O/c2-1(3)4/h(H4,2,3,4; Carbamimidic acid (VAN); U4128_SIGMA; Caswell No. 902; Spectrum_000672; Pastaron 20; U4883_SIGMA; CCRIS 989; 37955-36-5; Urea (8CI,9CI); U5128_SIAL; Varioform II; Pastaron 10; U0631_SIGMA; Harnstoff; Carbamide resin; Aqua Care; ARF; CHEBI:16199; Ureophil; Pseudourea; Ureacin-40 Creme; AIDS003652; C00086; KBioSS_001152; Optigen 1200; Spectrum5_001862; SPECTRUM1500604; Carbamimidic acid; 175276-38-7; U5378_SIGMA; carbamide; Spectrum2_001192; EINECS 200-315-5; Supercel 3000; Ureacin-10 lotion; IDI1_000086; component of Artra Ashy Skin Cream; Isourea; U4884_SIGMA; Urea solution; Aquacare; UREA; KBio2_006288; Rubinol ST 010; 51459_FLUKA; NSC34375; Aqua Care HP; Spectrum3_001791; Ultra Mide; Urepearl; uree; Prespersion, 75 urea; Urea-12C; Urea (JP15/USP); Carbonyldiamide; Harnstoff [German]; 4744-36-9; Aquadrate; Urea, homopolymer; 30535-50-3; Pastaron 20 soft; Urepeal; Carbonyl diamide; 33247_RIEDEL; Ureacin-20 | CH4N2O | 60.056 g/mol; 60.06 | C(=O)(N)N |
| TCMBANKIN057966 | CIR | C00327; EINECS 206-759-6; (2S)-2-amino-5-(carbamoylamino)pentanoic acid; (2S)-2-amino-5-ureidopentanoic acid; C7629_SIGMA; (2S)-2-amino-5-ureido-pentanoic acid; Citrulline, L-; alpha-Amino-delta-ureidovaleric acid; NSC 27425; (2S)-2-amino-5-(aminocarbonylamino)pentanoic acid; Ornithine, N5-(aminocarbonyl)-; N5-(Aminocarbonyl)ornithine; Ornithine, N5-carbamoyl-, L- (8CI); N(5)-(aminocarbonyl)-L-ornithine; SBB012374; N(delta)-Carbamylornithine; N(5)-carbamoyl-L-ornithine; (2S)-2-amino-5-ureido-valeric acid; (S)-2-Amino-5-ureidopentanoic acid; SMP1_000146; 2-Amino-5-ureidovaleric acid; NCGC00142602-01; L-2-Amino-5-ureidovaleric acid; delta-Ureidonorvaline; CHEBI:16349; citrulline; AB1007188; AC1LCUKE; d-citrullin; AK-58500; (R)-2-Amino-5-ureidopentanoic acid; MFCD00216469; KB-49607; D-Citruline; AX8031821; D-Ornithine,N5-(aminocarbonyl)-; W-204205; H-D-Orn(carbamoyl)-OH; (2R)-5-(aminocarbonylamino)-2-azanyl-pentanoic acid; DTXSID90348463; MolPort-003-928-964; 594C519; H-D-Cit-OH; D-Citrulline, >=99.0%; CTK4C0068; N(5)-carbamoyl-D-ornithine; AmbotzHAA1014; AJ-33795; AB0012765; ST24035348; ACM13594520; D-Citrulline; A807006; PubChem17499; TC-108738; J-300336; CHEBI:49007; SC-10122; C6H13N3O3; SCHEMBL437142; ANW-19993; AM82460; AS-12983; GTPL4683; ZINC2166829; FT-0659369; 13594-51-9; B-7191; D0V2DT; (2R)-2-amino-5-(carbamoylamino)pentanoic acid | C6H13N3O3 | 175.19 g/mol | C(CC(C(=O)O)N)CNC(=O)N |
| TCMBANKIN057992 | betaine | Betaine; Aristolochic acid; EINECS 258-258-7; Betaine aspartate; carboxy-n,n,n-trimethylmethanaminium(3s)-3-amino-3-carboxypropanoate; TRIMETHYL GLYCINE (+)-ASPARTATE; AC1L2WMU; D07524; betaine hydrochloride; Somathl (TN); glycine betaine; (2S)-2-amino-4-hydroxy-4-oxobutanoate; carboxymethyl(trimethyl)azanium; aristolochic acid A; AC1Q5T26 | C5H11NO2 | 117.15 g/mol | C[N+](C)(C)CC(=O)[O-] |
| TCMBANKIN058004 | trigonelline | Prestwick_70; N-Methylnicotinic acid betaine hydrochloride; 1-methyl-3-pyridin-1-iumcarboxylate hydrochloride; MFCD00077250; SCHEMBL468365; A833196; trigonelline ; trigonelline HCl; 1-methylpyridin-1-ium-3-carboxylate hydrochloride; AC1O4WFS; 1-Methylpyridinium-3-carboxylate hydrochloride; T-6500; CHEMBL489961; trigonellin; gynesine; trigonelline | C7H7NO2 | 137.14 g/mol | C[N+]1=CC=CC(=C1)C(=O)[O-] |
| TCMBANKIN058375 | tryptophan | (3s)2,3-dihydro-l-tryptophan; ZINC32141959;tryptophane;WV;L-tryptophan;HSDB 4142; Tryptophan, L-(8CI); AC1Q4U80; L-Tryptophan, Vetec(TM) reagent grade, >=98%; alpha-Aminoindole-3-propionic acid; SR-01000075590-1; ZINC83315; 1-beta-3-Indolylalanine; L-(-)-Tryptophane; MolPort-044-812-611; IDI1_000457; MFCD00064340; L-2-Amino-3-indolepropionic acid; 8DUH1N11BX; STR02722; NCGC00261868-01; EU-0101183; Lopac0_001183; Tryptophan, L-; 80206-30-0; Tryptophan, European Pharmacopoeia (EP) Reference Standard; (s)-a-amino-b-indolepropionate; Tox21_201246; L-Trytophan; bmse000868; TC-066620; (S)-2-amino-3-(1H-Indol-3-yl)-propionic acid; Sedanoct; UNII-8DUH1N11BX; L-Tryptophan, from non-animal source, meets EP, JP, USP testing specifications, suitable for cell culture, 99.0-101.0%; Propionic acid, 2-amino-3-indol-3-yl; Propionic acid, 2-amino-3-indol-3-yl-; NINDS_000457; NCI-C01729; (S)-alpha-Aminoindole-3-propionate; L-Tryptophan, Cell Culture Reagent; (S)-2-Amino-3-(1H-indol-3-yl)propanoic acid; bmse001017; AB1007074; tryptophan; BB_NC-1911; 2-amino-3-indol-3-ylpropionic acid; 154635-35-5; Pacitron; L-tryptophan; 2-Amino-3-indolylpropanoate; CTK2H7431; NCGC00094437-01; 2-Amino-3-indolylpropanoic acid; TRP NH3+ COOH; ZX-AT022248; L-Tryptophan, United States Pharmacopeia (USP) Reference Standard; (S)-2-Amino-3-(3-indolyl)propionic acid; Indole-3-alanine; HMS3263N07; L-TRYPTOPHAN SIGMA GRADE; alpha-Amino-3-Indoleproprionic Acid; Tryptophan (USP/INN); L-Tryptophan (9CI); D05EJG; A7403; (L)-TRYPTOPHAN; KSC377I3D; 1H-Indole-3-alanine; Alanine, 3-indol-3-yl-; NCGC00254424-01; MCULE-8004234494; (S)-1H-Indole-3-alanine; AKOS015854052; CHEBI:16828; LP01183; Lopac-T-0254; CHEMBL54976; GTPL717; 3-Indol-3-ylalanine; F0001-2364;HSDB 4142; MT1; T0254_SIAL; tryptophan (H-3); 1-beta-3-Indolylalanine; NChemBio.2007.20-comp7; IDI1_000457; EU-0101183; Lopac0_001183; 80206-30-0; (2S)-2-amino-3-(1H-indol-3-yl)propionic acid; Sedanoct; Propionic acid, 2-amino-3-indol-3-yl-; NINDS_000457; BB_NC-1911; Pacitron; 2-Amino-3-indolylpropanoic acid; (S)-2-Amino-3-(3-indolyl)propionic acid; Indole-3-alanine; (S)-alpha-Amino-beta-(3-indolyl)-propionic acid; Tryptophan (USP/INN); L-Tryptophan (9CI); (L)-TRYPTOPHAN; Alanine, 3-indol-3-yl-; AIDS011920; CHEBI:16828; AIDS-011920; Lopac-T-0254; 3-Indol-3-ylalanine; C00078; Tryptan; TRP-01; (S)-Tryptophan 1H-Indole-3-alanine, (S)-; (S)-Tryptophan; 1H-Indole-3-alanine (VAN); AI3-18478; LS-185087; L-alpha-Aminoindole-3-propionic acid; SMR000326686; L-Alanine, 3-(1H-indol-3-yl)-; L-Trp; L-alpha-Amino-3-indolepropionic acid; Tryptophane; 1H-Indole-3-propanoic acid, alpha-amino-, (S)-; (S)-alpha-Amino-1H-indole-3-propanoic acid; alpha-Amino-3-indolepropionic acid, L-; L-Tryptofan; 1H-Indole-3-alanine, (S)-; 1beta-3-Indolylalanine; (-)-Tryptophan; MLS001056750; alpha'-Amino-3-indolepropionic acid; Indoe-3-propionic acid, alpha-amino-; LTR; (2S)-2-amino-3-(1H-indol-3-yl)propanoic acid; Indole-3-propionic acid, alpha-amino-; (S)-alpha-Aminoindole-3-propionic acid; Alanine, 3-indol-3-yl; T8941_SIGMA; (S)-alpha-Amino-beta-indolepropionic acid; NSC 13119; CCRIS 617; L-Tryptophane; Tryptophane [French]; Tryptophanum [Latin]; 93659_FLUKA; D00020; Ardeytropin; DivK1c_000457; EINECS 200-795-6; EH 121; Tryptophan, L- (8CI); Triptofano [Spanish]; L-beta-3-Indolylalanine; KBio1_000457; L-(-)-tryptophan; Kalma; NCGC00015994-01; Lyphan; Tryptophan (VAN); h-Trp-oh; Tryptophan [USAN:INN]; L-Tryptophan (JP15); T4196_SIAL Pharmakon1600-01500600; triptofano; UNII-N7U7BXP2OI component QIVBCDIJIAJPQS-VIFPVBQESA-N; 2-Amino-3-(lH-indol-3-yl)-propanoic acid; DTXSID5021419; L-Ttp; Tryptophanum; AM82273; C00078; Tryptan; TRP-01; AJ-10635; L-Tryptophan, BioUltra, >=99.5% (NT); KB-53414; (S)-Tryptophan 1H-Indole-3-alanine, (S)-; (S)-Tryptophan; (S)-a-Aminoindole-3-propionic acid; 2a4m; L-Tryptophan, reagent grade, >=98% (HPLC); 1H-Indole-3-alanine (VAN); AI3-18478; trytophan; LS-185087; BIT0720; CS-W020011; L-alpha-Aminoindole-3-propionic acid; AC1L1M8F; QIVBCDIJIAJPQS-VIFPVBQESA-N; SMR000326686; D-Trp-OH; Tryptophan (L-Tryptophan); L-Alanine, 3-(1H-indol-3-yl)-; CAS-73-22-3; Tox21_501183; L-Trp; OR28930; T 0254; ST2419449; alpha-Amino-beta-(3-indolyl)-propionic acid; UNII-X9U7434L7A component QIVBCDIJIAJPQS-VIFPVBQESA-N; ZX-AFC000605; DSSTox_GSID_21419; Tryptophane; 73T223; 1H-Indole-3-propanoic acid, alpha-amino-, (S)-; (S)-alpha-Amino-1H-indole-3-propanoic acid; alpha-Amino-3-indolepropionic acid, L-; Epitope ID:136043; AX8034769; DSSTox_CID_1419; L-Tryptofan; S(-)-1-alpha-Aminoindole-3-propionic acid; 1H-Indole-3-alanine, (S)-; 1beta-3-Indolylalanine; PubChem10984; (-)-Tryptophan; BDBM21974; MLS001056750; (s)-alpha-amino-beta-indolepropionate; CCG-205257; alpha'-Amino-3-indolepropionic acid; NCGC00094437-02; Indoe-3-propionic acid, alpha-amino-; NSC757373; C-48302; (S)-a-Amino-b-indolepropionic acid; (2S)-2-amino-3-(1H-indol-3-yl)propanoic acid; Indole-3-propionic acid, alpha-amino-; (S)-alpha-Aminoindole-3-propionic acid; L(-)-Tryptophan; DSSTox_RID_76152; DB-029986; SR-01000075590; BP-13286; l-b-3-Indolylalanine; Alanine, 3-indol-3-yl; (S)-(-)-2-Amino-3-(3-indolyl)propionic Acid; ACT08662; DB00150; NCGC00258798-01; LS-1622; (S)-a-Amino-1H-indole-3-propanoic acid; (S)-alpha-Amino-beta-indolepropionic acid; NCGC00094437-04; BR-50074; AB00373874_05; RTC-066620; bmse000050; NSC 13119; L-Tryptophan, PharmaGrade, Ajinomoto, EP, JP, USP, Manufactured under appropriate GMP controls for pharma or biopharmaceutical production, suitable for cell culture; alpha-amino-beta-(3-indolyl)-pr opionic acid; GM0674; CCRIS 617; L-Tryptophane; Tryptophanum [Latin]; Tryptophane [French]; L-Tryptophan, certified reference material, TraceCERT(R); Tryptophan (H-3); (S)-a-Amino-1H-indole-3-propanoate; Tox21_300359; trp; AK-50074; Alti-Tryptophan; ANW-36308; Ardeytropin; D00020; DivK1c_000457; L-Tryptophan (JP17); (S)-(-)-Tryptopha n; NCGC00094437-03; L-Trp-OH; EINECS 200-795-6; (S)-2-Amino-3-(3-indolyl)propionic acid; L-; EH 121; EC 200-795-6; Optimax; L-Trytophane; HMS501G19; Tryptophan, L- (8CI); NSC-757373; M02943; (S)-(-)-Tryptophan; HTS001390; RP26086; Triptofano [Spanish]; (S)-alpha-amino-beta-(3-indolyl)-propionic acid; L-beta-3-Indolylalanine; A-Amino-3-indolepropionic acid; 151A3008-4CFE-40C9-AC0B-467EF0CB50EA; MolPort-001-794-499; KBio1_000457; BG00603884; 73-22-3; Kalma; NCGC00015994-01; AN-8742; 3-(1H-indol-3-yl)-L-Alanine; FT-0627592; Lyphan; Tryptophan (VAN); trofan; L-Tryptophan premix; L-Tryptophan, Vetec(TM), 98.5%; AC-17050; L-alpha-amino-3-indolepropionic acid; h-Trp-oh; 1qaw; SCHEMBL7328; Tryptophan [USAN:INN]; L-(-)-Tryptophan; L-Tryptophan (JP15); phosphatidylserine; (S)-alpha-Amino-1H-indole-3-propanoate; l-a-Aminoindole-3-propionic acid; D-2-Amino-3-indolepropionic acid; Z1245635763; (S)-a-Aminoindole-3-propionate; tryptacin | C11H12N2O2;C3H8NO6P | 204.22 g/mol;185.07g/mol | C1=CC=C2C(=C1)C(=CN2)CC(C(=O)O)N |
| TCMBANKIN058428 | isopsoralen | Sobatum; 2H-furo[2,3-h]chromen-2-one; (-)-; Furo[5',4':7,8]coumarin; 5-19-04-00447 (Beilstein Handbook Reference); 24-alpha-Ethylcholesterol; (24R)-Stigmast-5-en-3; Clionasterol; g-Sitosterol; ZINC6393492; A)-Stigmast-5-en-3-ol; NSC404563; 2H-Furo[2,3-h]-1-benzopyran-2-one; A-ol; delta5-Stigmasten-3-beta-ol; HSDB 3554; CHEBI:132823; EINECS 201-481-1; 24beta-Ethyl-5-cholesten-3beta-ol; 24S-Ethylcholest-5-en-3b-ol; CTK3E8527; Angelicin; Stigmast-5-en-3-beta-ol; 4-Hydroxy-5-benzofuranacrylic acid gamma-lactone; Angelicin (coumarin derivative); Poriferast-5-en-3beta-ol; Prostasal; CCRIS 4276; Isopsoralen; GAMMA-SITOSTEROL; AC-11107; .beta.-Dihydrofucosterol; furo[2,3-h]chromen-2-one; EINECS 201-480-6; angelicin ; (24S)-stigmast-5-en-3beta-ol; Betaprost; 24b-Ethylcholesterol; Stigmast-5-en-3-ol, (3.beta.,24S)-; 22,23-Dihydroporiferasterol; 39310-13-9; NSC 8096; Stigmast-5-en-3; 24-ethylcholest-5-en-3 beta-ol; Angelicin (coumarin deriv); ST023306; A-Ethylcholesterol; .gamma.-Sitosterol; KZJWDPNRJALLNS-OAIXMFQVSA-N; 24S-Ethylcholest-5-en-3.beta.-ol; beta-Dihydrofucosterol; Stigmast-5-en-3-ol, (3beta,24S)-; Oprea1_022970; C19654; CHEMBL393008; 2H-Furo(2,3-h)(1)benzopyran-2-one; (3-beta)-Stigmast-5-en-3-ol; ZINC00073700; AI3-26020; stigmast-5-ene-3beta-ol; LMST01040122; NSC 404563; 11027-08-0; NSC 18173; 8005-42-3; Angelicin plus ultraviolet A radiation [Angelicins]; b-Dihydrofucosterol; CCRIS 5529; (3beta,24S)-Stigmast-5-en-3-ol; CHEBI:28928; 24.beta.-Ethyl-5-cholesten-3.beta.-ol; BRN 0153970; 24.beta.-Ethylcholesterol; 24beta-Ethylcholesterol; (3S,8S,9S,10R,13R,14S,17R)-17-[(2R,5S)-5-ethyl-6-methylheptan-2-yl]-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol; Furo(5',4':7,8)coumarin; 4736-89-4; A-Sitosterol; AC1L9X94; 2-Propenoic acid, 3-(4-hydroxy-5-benzofuranyl)-, .delta.-lactone; 2-furo[2,3-h]chromenone; Furo(2,3-h)coumarin; 2-Propenoic acid, 3-(4-hydroxy-5-benzofuranyl)-, delta-lactone; 3-(4-Hydroxy-5-benzofuranyl)-2-propenoic acid gamma-lactone; isopsoralen; 2H-Furo(2,3-H)-1-benzopyran-2-one; 5LI01C78DD; A0956_SIGMA; Angecin; Ambotz83-46-5; 24b-Ethylcholest-5-en-3b-ol; 24S-Ethylcholest-5-en-3beta-ol; UNII-5LI01C78DD; 523-50-2; 2-Oxo-(2H)-furo(2,3-h)-1-benzopyran; 83-47-6; Stigmast-5-en-3-ol, (3b,24S)-; Stigmast-5-en-3.beta.-ol, (24S)-; 5-Stigmasten-3; Fucosterol, .beta.-dihydro-; C09060; sitosterol, (3beta)-isomer; LS-1826; AKOS025401337; (24R)-Ethylcholest-5-en-3; SCHEMBL219424 | C11H6O3 | 186.16 g/mol | C1=CC2=C(C=CO2)C3=C1C=CC(=O)O3 |
| TCMBANKIN058568 | paulownin; (+)-paulownin; isopaulownin; (-)-paulownin | Epipaulownin; (1R,3aR,4S,6aS)-1,4-bis(1,3-benzodioxol-5-yl)-3,3a,4,6-tetrahydro-1H-furo[3,4-c]furan-6a-ol; 13040-46-5; ACon1_001000; 1H,3H-Furo(3,4-c)furan-3a(4H)-ol, 1,4-bis(1,3-benzodioxol-5-yl)dihydro-, (1alpha,3aalpha,4alpha,6aalpha)-; ZINC05037439; MEGxp0_001306 | C20H18O7 | 370.35 | C1C2C(OCC2(C(O1)C3=CC4=C(C=C3)OCO4)O)C5=CC6=C(C=C5)OCO6 |
| TCMBANKIN059230 | isovalericacid | LS-2386; ST5213941; Iva; Butanoic acid , 3-methyl-; Butyric acid, 3-methyl-; Kyselina isovalerova [Czech]; W310212_ALDRICH; Isobutyl formic acid; beta-Methylbutyric acid; 92634-50-9; 503-74-2; CHEBI:28484; WLN: QV1Y1&1; EINECS 207-975-3; 3-Methylbutyrate; isovaleric acid; METHYLBUTANOIC ACID; 4-02-00-00895 (Beilstein Handbook Reference); InChI=1/C5H10O2/c1-4(2)3-5(6)7/h4H,3H2,1-2H3,(H,6,7; NSC62783; Isovaleric acid (natural); 3-Methylbuttersaeure; Delphinic acid; 129542_ALDRICH; AI3-24132; NSC 62783; Butanoic acid, 3-methyl-, (R)-; FEMA Number: 3102; 3-methyl-butanoic acid; Acetic acid, isopropyl-; Isovaleriansaeure; 3-Methylbutyric acid; C08262; 3,4-Diisovaleryl adrenaline; HSDB 629; Isovalerianic acid; .beta.-Methylbutyric acid; BRN 1098522; 59850_FLUKA; Isopropylacetic acid; LMFA01020181; Isobutylformic acid; FEMA No. 3102; Isovaleric acid; Butanoic acid, 3-methyl-; W310204_ALDRICH; Isopentanoic acid; Isovalerianic; 35915-22-1; 3-Methylbutanoic acid | C5H10O2 | 102.13 g/mol | CC(C)CC(=O)O |
| TCMBANKIN059394 | jatamansin | MolPort-003-665-745; 19427-82-8; HMS2193F07; AmbscZ-048430; BRD-K07212038-001-02-1; MLS002472947; Jatamansin; SCHEMBL12062120; [(9R)-8,8-dimethyl-2-oxo-9,10-dihydropyrano[2,3-h]chromen-9-yl] (Z)-2-methylbut-2-enoate; Selinidin; SPECTRUM1504159; CHEMBL457257; ZINC28040; Xanthogalin; SDCCGMLS-0066791.P001; AC1LDJE7; BDBM50069685; SMR001397055; BSPBio_003337; J3.496.931K; Spectrum5_000398; (Z)-2-Methyl-2-butenoic acid (9R)-8,8-dimethyl-2-oxo-9,10-dihydro-2H,8H-benzo[1,2-b:3,4-b']dipyran-9-yl ester | C19H20O5 | 328.4 g/mol | CC=C(C)C(=O)OC1CC2=C(C=CC3=C2OC(=O)C=C3)OC1(C)C |
| TCMBANKIN059458 | jatamansinol;Lomatin | C14H14O4 | 246.26 g/mol | CC1(C(CC2=C(O1)C=CC3=C2OC(=O)C=C3)O)C | |
| TCMBANKIN059521 | B- pinene;pinene;T-pinene;(-)-nopinene;beta-pinene;bicyclo[3.1.1]heptane,6,6-dimethyl-2-methylene-,(1s);1-β-pinene;()-beta-Pinene;(-)- β- pinene;laevo- β- Pinene | C10H16 | 136.23 g/mol | CC1(C2CCC(=C)C1C2)C | |
| TCMBANKIN059531 | eucalyptol | C10H18O | 154.25 g/mol | CC1(C2CCC(O1)(CC2)C)C | |
| TCMBANKIN059881 | (+-)-car-3-ene-2,5-dione | C10H12O2 | 164.2 g/mol | CC1=CC(=O)C2C(C1=O)C2(C)C | |
| TCMBANKIN059947 | vitamin b1 | C63H88CoN14O14P | 1356.4 g/mol | CC1=CC2=C(C=C1C)N(C=N2)C3C(C(C(O3)CO)OP(=O)(O)OC(C)CNC(=O)CCC4(C(C5C6(C(C(C(=N6)C(=C7C(C(C(=N7)C=C8C(C(C(=N8)C(=C4[N-]5)C)CCC(=O)N)(C)C)CCC(=O)N)(C)CC(=O)N)C)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)C)O.[C-]#N.[Co+2] | |
| TCMBANKIN060468 | (+)-calaren | C15H24 | 204.35 | CC1CCC=C2C1(C3C(C3(C)C)CC2)C | |
| TCMBANKIN060566 | β-patchoulene | C15H24 | 204.35 | CC1CCC2=C1CC3CCC2(C3(C)C)C | |
| TCMBANKIN060604 | aristolene;9-aristolene | C15H24 | 204.35 | CC1CCCC2=CCC3C(C12C)C3(C)C | |
| TCMBANKIN060679 | stigmasterol | C29H48O | 412.7 g/mol | CCC(C=CC(C)C1CCC2C1(CCC3C2CC=C4C3(CCC(C4)O)C)C)C(C)C | |
| TCMBANKIN060803 | pentanoic acid | C5H10O2 | 102.13 g/mol | CCCCC(=O)O | |
| TCMBANKIN060879 | Linolic acid | C18H32O2 | 280.4 g/mol | CCCCCC=CCC=CCCCCCCCC(=O)O | |
| TCMBANKIN061058 | n-hexadecane | C16H34 | 226.44 g/mol | CCCCCCCCCCCCCCCC | |
| TCMBANKIN061100 | nonadecane | C19H40 | 268.5 g/mol | CCCCCCCCCCCCCCCCCCC |
植物对应的疾病
| 疾病ID | 病名 | 疾病类型 | MeSH | 参考文献 |
|---|
植物对应的靶点
| 靶点ID | 基因名 | 基因别名 | 描述 | 染色体位置 | Map_Location | 基因类型 |
|---|
滇ICP备16009434号-1 |
Dai SX Lab